Literature DB >> 24801599

TGFBI, CHST6, and GSN gene analysis in Mexican patients with stromal corneal dystrophies.

Johanna Gonzalez-Rodriguez1, Arturo Ramirez-Miranda, Sergio E Hernandez-Da Mota, Juan C Zenteno.   

Abstract

OBJECTIVES: The purpose of our study was to describe the results of molecular screening of TGFBI, CHST6, and GSN genes in a group of Mexican patients with different stromal corneal dystrophies (CD).
MATERIAL AND METHODS: A total of 16 CD Mexican patients pertaining to nine different pedigrees were subjected to a complete ophthalmological investigation. A clinical diagnosis of lattice CD was performed in 10 patients from five pedigrees. Three patients from two pedigrees were diagnosed with granular CD type 2, two patients with unrelated probands had Finnish-type corneal amyloidosis, and one patient had macular CD. Genetic analysis included DNA isolation from blood leukocytes and polymerase chain reaction (PCR) amplification and direct nucleotide sequencing of TGFBI, CHST6, and GSN genes.
RESULTS: Seven lattice CD patients from four unrelated families had an identical p.H626R mutation in TGFBI, three patients from a single lattice CD family carried a p.R124C substitution in TGFBI, and a granular type 2 CD pedigree was demonstrated to carry a heterozygous TGFBI p.M619K substitution. A patient having Finnish-type corneal amyloidosis had a p.D187N mutation in GSN. Finally, molecular analysis of CHST6 in a patient with macular CD disclosed the presence of a homozygous p.Y110C change.
CONCLUSIONS: This study improves the knowledge of the genetic features of Mexican patients with corneal stromal dystrophies by identifying mutations in the TGFBI, CHST6, and GSN genes. Genetic screening of larger samples of patients from distinct ethnic groups would be of great importance for a better understanding of the mutational spectrum of stromal CD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24801599     DOI: 10.1007/s00417-014-2648-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  30 in total

1.  Corneal dystrophies: molecular genetics to therapeutic intervention--Fifth ARVO/Pfizer Ophthalmics Research Institute Conference.

Authors:  Jayne S Weiss
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-11       Impact factor: 4.799

Review 2.  Genetics of corneal dystrophies: the evolving landscape.

Authors:  Sean F Pieramici; Natalie A Afshari
Journal:  Curr Opin Ophthalmol       Date:  2006-08       Impact factor: 3.761

3.  Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene.

Authors:  C P Maury; J Kere; R Tolvanen; A de la Chapelle
Journal:  FEBS Lett       Date:  1990-12-10       Impact factor: 4.124

Review 4.  Advances in the molecular genetics of corneal dystrophies.

Authors:  G K Klintworth
Journal:  Am J Ophthalmol       Date:  1999-12       Impact factor: 5.258

5.  Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene.

Authors:  T O Akama; K Nishida; J Nakayama; H Watanabe; K Ozaki; T Nakamura; A Dota; S Kawasaki; Y Inoue; N Maeda; S Yamamoto; T Fujiwara; E J Thonar; Y Shimomura; S Kinoshita; A Tanigami; M N Fukuda
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

6.  Granular and lattice deposits in corneal dystrophy caused by R124C mutation of TGFBIp.

Authors:  Dhara A Patel; Shu-Hong Chang; George J Harocopos; Smita C Vora; Diep Huu Thang; Andrew J W Huang
Journal:  Cornea       Date:  2010-11       Impact factor: 2.651

Review 7.  Analysis of TGFBI gene mutations in Chinese patients with corneal dystrophies and review of the literature.

Authors:  Juhua Yang; Xiaoli Han; Dinggou Huang; Lin Yu; Yihua Zhu; Yi Tong; Binliang Zhu; Chuanbao Li; Mingshe Weng; Xu Ma
Journal:  Mol Vis       Date:  2010-06-30       Impact factor: 2.367

8.  A novel variant of combined granular-lattice corneal dystrophy associated with the Met619Lys mutation in the TGFBI gene.

Authors:  Anthony J Aldave; Vivek S Yellore; Baris Sonmez; Nirit Bourla; Andrew K Salem; M Ali Khan; Sylvia A Rayner; Ben J Glasgow
Journal:  Arch Ophthalmol       Date:  2008-03

9.  Lattice corneal dystrophy type II: clinical, pathologic, and molecular study in a Spanish family.

Authors:  V Huerva; A Velasco; M C Sánchez; A J Mateo; X Matías-Guiu
Journal:  Eur J Ophthalmol       Date:  2007 May-Jun       Impact factor: 2.597

10.  Clinical and genetic features of TGFBI-linked corneal dystrophies in Mexican population: description of novel mutations and novel genotype-phenotype correlations.

Authors:  Juan Carlos Zenteno; Vicente Correa-Gomez; Concepción Santacruz-Valdez; Raul Suarez-Sanchez; Cristina Villanueva-Mendoza
Journal:  Exp Eye Res       Date:  2009-03-18       Impact factor: 3.467

View more
  3 in total

1.  Genetic analysis of CHST6 and TGFBI in Turkish patients with corneal dystrophies: Five novel variations in CHST6.

Authors:  Fulya Yaylacioglu Tuncay; Gülsüm Kayman Kurekci; Sezen Guntekin Ergun; Ozge Tugce Pasaoglu; Rustu Fikret Akata; Pervin Rukiye Dincer
Journal:  Mol Vis       Date:  2016-10-26       Impact factor: 2.367

2.  A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy.

Authors:  Jing Zhang; Dan Wu; Yue Li; Yidan Fan; Yiqin Dai; Jianjiang Xu
Journal:  Aging (Albany NY)       Date:  2019-02-04       Impact factor: 5.682

3.  Clinical, histopathological, and in silico pathogenicity analyses in a pedigree with familial amyloidosis of the Finnish type (Meretoja syndrome) caused by a novel gelsolin mutation.

Authors:  Jesus Cabral-Macias; Leopoldo A Garcia-Montaño; Mario Pérezpeña-Díazconti; Marisa-Cruz Aguilar; Guillermo Garcia; Carlos I Vencedor-Meraz; Enrique O Graue-Hernandez; Oscar F Chacón-Camacho; Juan C Zenteno
Journal:  Mol Vis       Date:  2020-05-02       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.